These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 385025)

  • 61. [Clinical use of bumetanide].
    Pellerito R; Bertola D; Soragna A
    Clin Ter; 1981 Sep; 98(6):651-60. PubMed ID: 7285545
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.
    Marone C; Reubi FC; Lahn W
    Eur J Clin Pharmacol; 1984; 26(4):413-8. PubMed ID: 6734705
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bumetanide: potent new "loop" diuretic.
    Asbury MJ; Gatenby PB; O'Sullivan S; Bourke E
    Br Med J; 1972 Jan; 1(5794):211-3. PubMed ID: 4550872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Chronic cardiac insufficiency. Treatment with a vasoactive diuretic. Effectiveness and tolerance of piretanide (Arelix mite)].
    Schöpp W
    ZFA (Stuttgart); 1983 Nov; 59(31):1767-72. PubMed ID: 6659668
    [No Abstract]   [Full Text] [Related]  

  • 67. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 68. Bumetanide: a new potent diuretic. The effects of a single intravenous dose in patients with congestive heart failure.
    Sigurd B; Hesse B; Valentin N
    Dan Med Bull; 1974 Apr; 21(2):63-7. PubMed ID: 4830521
    [No Abstract]   [Full Text] [Related]  

  • 69. Activity of a new high efficiency diuretic in man: piretanide (HOE 118).
    Pozet N; Hadj-Aissa A; Pellet M; Traeger J
    Br J Clin Pharmacol; 1980 Jun; 9(6):577-83. PubMed ID: 7387813
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Investigations with intravenous bumetanide.
    Sigurd B; Hesse B; Bollerup AC; Valentin N
    Postgrad Med J; 1975; 51 Suppl 6():27-34. PubMed ID: 1105530
    [No Abstract]   [Full Text] [Related]  

  • 71. Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiency.
    Hadj Aissa A; Pozet N; Labeeuw M; Pellet M; Traeger J
    Br J Clin Pharmacol; 1981 Jan; 11(1):63-8. PubMed ID: 7213511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of adverse reactions to bumetanide and furosemide.
    Tuzel IH
    J Clin Pharmacol; 1981; 21(11):615-9. PubMed ID: 7338572
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gentamicin-induced nephrotoxicity in mice: protection by loop diuretics.
    Whiting PH; Petersen J; Simpson JG
    Br J Exp Pathol; 1981 Apr; 62(2):200-6. PubMed ID: 7236500
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Severe musculoskeletal symptoms during continuous infusion of bumetanide.
    Howard PA; Dunn MI
    Chest; 1997 Feb; 111(2):359-64. PubMed ID: 9041982
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction.
    Galløe AM; Skagen K; Christensen NJ; Nielsen SL; Frandsen EK; Bie P; Dalgaard P; Larsen K
    J Clin Pharm Ther; 2006 Apr; 31(2):139-47. PubMed ID: 16635047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bumetanide--acute and long-term studies of a new high potency diuretic.
    Murdoch WR; Auld WH
    Postgrad Med J; 1975; 51 Suppl 6():64-69. PubMed ID: 1105535
    [No Abstract]   [Full Text] [Related]  

  • 77. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide.
    Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
    J Bone Miner Res; 2006 Jan; 21(1):163-70. PubMed ID: 16355285
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patient tolerance of long-term diuretic/potassium supplement therapy.
    Singh BB; Watt DA
    Curr Med Res Opin; 1976; 4(2):117-23. PubMed ID: 1277878
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Renal function during therapy in patients with congestive cardiac failure. Ticrynafen vs. hydrochlorothiazide.
    Smith JW; Clements P
    Nephron; 1979; 23 Suppl 1():41-5. PubMed ID: 381954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.